Chemokine receptors and their crucial role in human immunodeficiency virus infection: major breakthroughs in HIV research. (Q45753164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Chemokine receptors and their crucial role in human immunodeficiency virus infection: major breakthroughs in HIV research (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

T B Kristiansen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T B Knudsen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

339-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9790302%20AND%20SRC:MED&resulttype=core&format=json

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Expression cloning of new receptors used by simian and human immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The antigenic structure of the HIV gp120 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

HIV. Envelope's letters boxed into shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

A new classification for HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SF

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progres

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Coreceptors--Implications for HIV Pathogenesis and Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Chemokines and HIV-1 second receptors: the therapeutic connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

CCR5-Δ32 gene deletion in HIV-1 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

HIV-1 subtype and second-receptor use

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X

HIV-Infected Individuals With the CCR5Δ32/CCR5 Genotype Have Lower HIV RNA Levels and Higher CD4 Cell Counts in the Early Years of the Infection Than Do Patients With the Wild Type

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.1998.00438.X